News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
760,433 Results
Type
Article (46197)
Company Profile (341)
Press Release (713873)
Multimedia
Podcasts (133)
Webinars (24)
Section
Business (213168)
Career Advice (2129)
Deals (36663)
Drug Delivery (142)
Drug Development (83101)
Employer Resources (177)
FDA (17162)
Job Trends (15491)
News (358937)
Policy (33801)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2766)
Accelerated approval (48)
Adcomms (27)
Allergies (172)
Alliances (52857)
ALS (203)
Alzheimer's disease (1828)
Antibody-drug conjugate (ADC) (453)
Approvals (17495)
Artificial intelligence (688)
Autoimmune disease (258)
Automation (56)
Bankruptcy (367)
Best Places to Work (11970)
BIOSECURE Act (20)
Biosimilars (219)
Biotechnology (228)
Bladder cancer (186)
Brain cancer (72)
Breast cancer (727)
Cancer (5747)
Cardiovascular disease (464)
Career advice (1808)
Career pathing (42)
CAR-T (330)
CDC (56)
Celiac Disease (2)
Cell therapy (886)
Cervical cancer (45)
Clinical research (71620)
Collaboration (2115)
Company closure (5)
Compensation (1346)
Complete response letters (80)
COVID-19 (2847)
CRISPR (112)
C-suite (1102)
Cystic fibrosis (156)
Data (7575)
Decentralized trials (3)
Denatured (47)
Depression (164)
Dermatology (72)
Diabetes (570)
Diagnostics (7190)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (329)
Drug pricing (203)
Drug shortages (34)
Duchenne muscular dystrophy (283)
Earnings (93150)
Editorial (66)
Employer branding (22)
Employer resources (157)
Events (124171)
Executive appointments (1108)
FDA (20834)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1748)
Gene editing (241)
Generative AI (65)
Gene therapy (730)
GLP-1 (1057)
Government (4865)
Grass and pollen (7)
Guidances (406)
Healthcare (19761)
HIV (80)
Huntington's disease (55)
IgA nephropathy (97)
Immunology and inflammation (288)
Immuno-oncology (89)
Indications (170)
Infectious disease (3193)
Inflammatory bowel disease (212)
Inflation Reduction Act (14)
Influenza (141)
Intellectual property (286)
Interviews (333)
IPO (17020)
IRA (51)
Job creations (3851)
Job search strategy (1507)
JPM (63)
Kidney cancer (18)
Labor market (97)
Layoffs (579)
Leadership (40)
Legal (8186)
Liver cancer (101)
Longevity (31)
Lung cancer (765)
Lymphoma (425)
Machine learning (61)
Management (63)
Manufacturing (1022)
MASH (183)
Medical device (14674)
Medtech (14767)
Mergers & acquisitions (20862)
Metabolic disorders (1469)
mRNA (216)
Multiple sclerosis (183)
NASH (17)
Neurodegenerative disease (410)
Neuropsychiatric disorders (102)
Neuroscience (3319)
Neurotech (1)
NextGen: Class of 2026 (6884)
Non-profit (4702)
Now hiring (75)
Obesity (686)
Opinion (305)
Ovarian cancer (211)
Pain (246)
Pancreatic cancer (287)
Parkinson's disease (357)
Partnered (38)
Patents (585)
Patient recruitment (645)
Peanut (64)
People (61958)
Pharmaceutical (68)
Pharmacy benefit managers (32)
Phase 1 (22471)
Phase 2 (31501)
Phase 3 (23401)
Pipeline (7868)
Policy (323)
Postmarket research (2595)
Preclinical (9646)
Press Release (71)
Prostate cancer (289)
Psychedelics (54)
Radiopharmaceuticals (338)
Rare diseases (1067)
Real estate (6328)
Recruiting (70)
Regulatory (26019)
Reports (56)
Research institute (2582)
Resumes & cover letters (365)
Rett syndrome (35)
RNA editing (23)
RSV (90)
Schizophrenia (175)
Series A (293)
Series B (214)
Service/supplier (15)
Sickle cell disease (112)
Special edition (25)
Spinal muscular atrophy (168)
Sponsored (48)
Startups (3920)
State (2)
Stomach cancer (20)
Supply chain (129)
Tariffs (88)
The Weekly (83)
Vaccines (1127)
Venture capital (108)
Weight loss (445)
Women's health (123)
Worklife (20)
Date
Today (165)
Last 7 days (719)
Last 30 days (2782)
Last 365 days (31270)
2026 (10359)
2025 (31170)
2024 (36370)
2023 (41304)
2022 (52542)
2021 (57169)
2020 (55789)
2019 (48566)
2018 (36568)
2017 (33656)
2016 (33260)
2015 (39464)
2014 (33059)
2013 (28096)
2012 (30338)
2011 (30934)
2010 (28886)
Location
Africa (787)
Alabama (94)
Alaska (7)
Arizona (354)
Arkansas (16)
Asia (42480)
Australia (7080)
California (12967)
Canada (3673)
China (1327)
Colorado (557)
Connecticut (572)
Delaware (396)
Europe (93735)
Florida (1920)
Georgia (423)
Hawaii (3)
Idaho (67)
Illinois (1051)
India (90)
Indiana (592)
Iowa (24)
Japan (524)
Kansas (133)
Kentucky (50)
Louisiana (41)
Maine (75)
Maryland (1560)
Massachusetts (9342)
Michigan (380)
Minnesota (721)
Mississippi (7)
Missouri (155)
Montana (36)
Nebraska (29)
Nevada (143)
New Hampshire (91)
New Jersey (3431)
New Mexico (31)
New York (3438)
North Carolina (1686)
North Dakota (10)
Northern California (6426)
Ohio (389)
Oklahoma (26)
Oregon (45)
Pennsylvania (2597)
Puerto Rico (29)
Rhode Island (51)
South America (1176)
South Carolina (86)
South Dakota (2)
Southern California (5101)
Tennessee (207)
Texas (2063)
United States (46123)
Utah (391)
Vermont (1)
Virginia (311)
Washington D.C. (82)
Washington State (1052)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
760,433 Results for "accelerated technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Drug pricing watchdog calls for increased transparency into FDA’s accelerated approval decisions
Greater transparency in FDA decision-making was possibly the most common theme for stakeholders interviewed by the Institute for Clinical and Economic Review in a new report focused on strengthening the agency’s accelerated approval program.
April 16, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth
March 11, 2026
·
6 min read
Press Releases
Sonablate Expands Leadership to Accelerate Growth in Incision-Free Prostate Care Solutions
April 10, 2026
·
5 min read
Press Releases
Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy
April 21, 2026
·
2 min read
Press Releases
Minnesota Medical Technologies Corporation Secures $20 Million in Series A Funding to Accelerate Growth
March 5, 2026
·
4 min read
Press Releases
Semarion Secures $3.8 Million to Scale Next-Generation Cell Assay Technology and Accelerate Pharma Adoption
March 31, 2026
·
3 min read
Press Releases
Avandra Appoints Two Seasoned Healthcare Technology Leaders to Accelerate Commercial Growth
February 19, 2026
·
2 min read
Press Releases
Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to Accelerate Growth
February 12, 2026
·
2 min read
Press Releases
Integrated DNA Technologies Unveils NGS Innovation Roadmap to Accelerate the Future of Cancer Research
February 23, 2026
·
4 min read
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
1 of 76,044
Next
